Proteotype Launches Alchemi® Data and Orchestration Platform
Proteotype has unveiled its Alchemi® data and orchestration platform designed to connect laboratory measurements, multi-country clinical data, and healthcare workflows. The development is supported by €499,000 in funding from the EIC Pre-Accelerator.
Proteotype, a technology company based in Torres Vedras, Portugal, has announced the launch of its Alchemi® data and orchestration platform. The platform is engineered to connect laboratory measurements, multi-country clinical data, and healthcare workflows.
The development of Alchemi® is being supported by approximately €499,000 in funding from the EIC Pre-Accelerator initiative. This investment is intended to facilitate the platform's advancement and enhance its capabilities in managing complex data streams within the healthcare sector.
Alchemi® serves as the underlying technology for Proteotype's Enlighten® solution. The platform aims to provide a secure and interoperable method for integrating various data sources, potentially streamlining operations and improving decision-making for organizations reliant on distributed laboratory networks.
The platform's design emphasizes secure data exchange and interoperability across distributed laboratories and healthcare systems. Proteotype's focus is on enabling seamless data flow to support clinical research and healthcare operations.